Literature DB >> 11373829

Management of intraocular inflammatory disease.

A van der Woerdt1.   

Abstract

The uvea of the eye is divided into the anterior uvea (iris and ciliary body) and posterior uvea (choroid). Clinical signs of anterior uveitis include conjunctival hyperemia, corneal edema, aqueous flare, miosis, and a decrease in intraocular pressure. Inflammation of the posterior uvea often involves the retina as well resulting in a chorioretinitis. Clinical signs of chorioretinitis may include multifocal lesions in tapetal or nontapetal fundus, retinal detachment, and a decrease in vision. The etiology of uveitis is complex and includes numerous infectious, neoplastic, immune-mediated, and other diseases. Treatment is directed at the underlying systemic disease, if present, as well as symptomatic treatment for the eye. The diagnostic and therapeutic approach to a patient with uveitis is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11373829     DOI: 10.1053/svms.2001.22807

Source DB:  PubMed          Journal:  Clin Tech Small Anim Pract        ISSN: 1096-2867


  4 in total

1.  Automated hyperemia analysis software: reliability and reproducibility in healthy subjects.

Authors:  Tsuyoshi Yoneda; Tamaki Sumi; Ayako Takahashi; Yasuhiro Hoshikawa; Masahiko Kobayashi; Atsuki Fukushima
Journal:  Jpn J Ophthalmol       Date:  2011-12-01       Impact factor: 2.447

Review 2.  Ocular manifestations of systemic disease in cats.

Authors:  Noelle C La Croix
Journal:  Clin Tech Small Anim Pract       Date:  2005-05

Review 3.  The Application of Artificial Intelligence in the Analysis of Biomarkers for Diagnosis and Management of Uveitis and Uveal Melanoma: A Systematic Review.

Authors:  Arshpreet Bassi; Saffire H Krance; Aidan Pucchio; Daiana R Pur; Rafael N Miranda; Tina Felfeli
Journal:  Clin Ophthalmol       Date:  2022-08-30

4.  Management of bilateral uveitis in a Toxoplasma gondii-seropositive cat with histopathologic evidence of fungal panuveitis.

Authors:  J Pearce; E A Giuliano; L E Galle; G Klauss; J Ota; C P Moore
Journal:  Vet Ophthalmol       Date:  2007 Jul-Aug       Impact factor: 1.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.